SCHEMBL14964686

SCHEMBL14964686

COc1ccc(-c2[c]cccn2)nn1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.34
MAOB P27338 4/20 0.33
KDM4E B2RXH2 2/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
ALDH1A1 P00352 1/20 0.33
TP53 P04637 1/20 0.33
PKM P14618 1/20 0.33
HPGD P15428 1/20 0.33
ALOX15 P16050 1/20 0.33
HTT P42858 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HSD17B10 Q99714 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
NNMT P40261 1/20 0.32
MAPT P10636 3/20 0.32
TXNRD1 Q16881 1/20 0.31
GAA P10253 1/20 0.30
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL38086 0.72 LMNA (0.38) LMNAMAOBKDM4ENPC1RAB9A
SCHEMBL1457173 0.72 KDM4E (0.69) LMNAKDM4ENPC1RAB9AALDH1A1
SCHEMBL1456221 0.71 NNMT (0.46) LMNAMAOBKDM4ENPC1RAB9A
SCHEMBL1967426 0.69 CLK4 (0.56) KDM4ENPC1RAB9AALDH1A1PKM
SCHEMBL1450475 0.69 KDM4E (0.54) LMNAKDM4ENPC1RAB9AALDH1A1
SCHEMBL751581 0.69 HDAC8 (0.33) LMNAKDM4E
SCHEMBL1967614 0.68 ALDH1A1 (0.43) LMNAKDM4ENPC1RAB9AALDH1A1
SCHEMBL18228114 0.67
SCHEMBL3827760 0.67
SCHEMBL16048094 0.67 TRIM24 (0.41) LMNAMAOBNPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2780332-A1 MORPHOLINYL BENZOTRIAZINE FOR USE IN CANCER THERAPY Merck Patent GmbH (DE) 2014-09-24 EP disclosed
WO-2013072015-A1 MORPHOLINYL BENZOTRIAZINE FOR USE IN CANCER THERAPY MERCK PATENT GMBH (DE) 2013-05-23 WO disclosed